Omega Fund Management as of June 30, 2026
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 10 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bicara Therapeutics Common Stock (BCAX) | 29.1 | $54M | 1.8M | 29.69 | |
| Nuvation Bio Common Stock Class A (NUVB) | 24.7 | $46M | 8.1M | 5.68 | |
| Kestra Med Technologies Common Stock (KMTS) | 14.0 | $26M | 1.0M | 25.44 | |
| BridgeBio Oncology Therapeutics Common Stock (BBOT) | 13.5 | $25M | 3.3M | 7.62 | |
| Beta Bionics Common Stock (BBNX) | 11.1 | $21M | 1.3M | 15.67 | |
| Alumis Common Stock (ALMS) | 3.7 | $6.8M | 241k | 28.14 | |
| Sana Biotechnology Common Stock (SANA) | 1.6 | $2.9M | 844k | 3.49 | |
| ImageneBio Common Stock (IMA) | 1.4 | $2.7M | 455k | 5.90 | |
| enGene Holdings Common Stock | 0.8 | $1.5M | 876k | 1.73 | |
| Odyssey Therapeutics Common Stock | 0.0 | $54k | 2.9k | 18.71 |
